Clinical trial
Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesion
NCT07122167 is registered in ClinicalTrials.gov with MDCECRO LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesion
- Lead sponsor
- MDCECRO LLC
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 2, 2025
- Completion date
- February 1, 2027
- Enrollment
- 153 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.